123 related articles for article (PubMed ID: 20175704)
1. Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression.
Mohamed F; Vincent N; Cottier M; Peoc'h M; Merrouche Y; Patouillard B; Paul S; Genin C
Biomarkers; 2010 Jun; 15(4):315-24. PubMed ID: 20175704
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.
Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775
[TBL] [Abstract][Full Text] [Related]
3. Detection of mRNAs of GA733 genes by RT-PCR in exfoliated cells of pleural and peritoneal effusions and its clinical values.
Zhang KH; Cao F; Fu QB; Zhu JQ; Chen J; Lv NH
Intern Med; 2007; 46(18):1489-94. PubMed ID: 17878632
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic role of claudins in serous effusions.
Kleinberg L; Holth A; Fridman E; Schwartz I; Shih IeM; Davidson B
Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
Sun W; Li J; Jiang HG; Ge LP; Wang Y
QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
[TBL] [Abstract][Full Text] [Related]
6. [Advances in research on markers for differential diagnosis of malignant tumor cells in body cavity effusion].
Tu P; Li WC; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):854-6. PubMed ID: 22336217
[No Abstract] [Full Text] [Related]
7. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
[TBL] [Abstract][Full Text] [Related]
8. Real-time reverse transcription-polymerase chain reaction assay for GA733-2 mRNA in the detection of metastatic carcinoma cells in serous effusions.
Nagel H; Werner C; Hemmerlein B
Am J Clin Pathol; 2003 Dec; 120(6):888-901. PubMed ID: 14671978
[TBL] [Abstract][Full Text] [Related]
9. Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion.
Yu CJ; Shew JY; Liaw YS; Kuo SH; Luh KT; Yang PC
Am J Respir Crit Care Med; 2001 Oct; 164(7):1312-8. PubMed ID: 11673227
[TBL] [Abstract][Full Text] [Related]
10. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
11. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.
Wang T; Qian X; Wang Z; Wang L; Yu L; Ding Y; Liu B
Int J Cancer; 2009 Oct; 125(8):1921-5. PubMed ID: 19585499
[TBL] [Abstract][Full Text] [Related]
12. Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.
Roca E; Lacroix R; Judicone C; Laroumagne S; Robert S; Cointe S; Muller A; Kaspi E; Roll P; Brisson AR; Tantucci C; Astoul P; Dignat-George F
Oncotarget; 2016 Jan; 7(3):3357-66. PubMed ID: 26689993
[TBL] [Abstract][Full Text] [Related]
13. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
Pillai V; Cibas ES; Dorfman DM
Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.
Son SM; Han HS; An JY; Choe KH; Lee KM; Lee KH; Kim SS; Lee YM; Lee HC; Song HG; Lee OJ
Pathology; 2015 Feb; 47(2):123-9. PubMed ID: 25551300
[TBL] [Abstract][Full Text] [Related]
15. Immunological screening for tumor cells in serous body fluids has added value with the CELL-DYN Sapphire.
Keuren JF; Hoffmann JJ; Leers MP
Clin Chem Lab Med; 2014 Feb; 52(2):253-8. PubMed ID: 24096441
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous expression of tumor-associated genes in disseminated breast cancer cells.
Zieglschmid V; Hollmann C; Gutierrez B; Krehan A; Kaul S; Böcher O
Anticancer Res; 2007; 27(4A):1769-76. PubMed ID: 17649771
[TBL] [Abstract][Full Text] [Related]
17. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites.
Trapé J; Gurt G; Franquesa J; Montesinos J; Arnau A; Sala M; Sant F; Casado E; Ordeig JM; Bergos C; Vida F; Sort P; Isava Á; González M; Molina R
Anticancer Res; 2015 Oct; 35(10):5655-60. PubMed ID: 26408739
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions.
Lonardi S; Manera C; Marucci R; Santoro A; Lorenzi L; Facchetti F
Diagn Cytopathol; 2011 May; 39(5):313-7. PubMed ID: 21488172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
